The minister joined the docs and potential vaccine beneficiaries on the All India Institute of Medical Sciences (AIIMS), New Delhi, to witness the launch of the nationwide Covid-19 vaccination, the place a sanitation employee turns into the primary particular person to obtain the vaccine.
Addressing the media he stated that misinformation is being unfold concerning the vaccines and urged the media to assist in dispelling the rumours.
“I am very happy and satisfied today. We have been fighting against Covid-19 under Prime Minister Narendra Modi‘s leadership for the last one year. With help of doctors and scientists, we have an Indian vaccine now, this vaccine will work as a ‘sanjeevani’ in the fight against Covid-19, which has entered the final stage,” Dr Harsh Vardhan stated.
He later held up a dose of COVAXIN developed by Bharat Biotech to the media.
Prime Minister Narendra Modi on Saturday launched India’s vaccination drive in opposition to the novel coronavirus through video conferencing.
A complete of three,006 session websites throughout all States and Union Territories might be nearly linked in the course of the launch. Around 100 beneficiaries might be vaccinated at every session website on the inaugural day.
Billed because the world’s largest vaccination program, overlaying the whole size and breadth of the nation, the drive goals to first inoculate thousands and thousands of its healthcare and frontline staff and attain an estimated three crore individuals by the tip of its first part.
Meanwhile, chief ministers of a number of states attended the launch of the vaccination drive at authorities hospitals of their respective states.
Andhra Pradesh chief minister YS Jaganmohan Reddy attended the launch of the Covid-19 vaccination programme at Government General Hospital, Vijayawada, whereas Madhya Pradesh chief minister Shivraj Singh Chouhan attended the inaugural occasion at Gandhi Hospital in Bhopal.
The medication regulatory physique of India has at present authorized two vaccines. Pune-based Serum Institute of India has developed the Covishield vaccine developed by AstraZeneca and Oxford University whereas the Covaxin has been developed by Hyderabad’s Bharat Biotech in collaboration with the Indian Medical Council of analysis (ICMR) and National Institute of Virology.
According to the Union well being ministry, the complete preliminary procurement quantity of 1.65 crore doses of Covishield and Covaxin vaccines in opposition to Covid-19 have been allotted to all States/UTs within the proportion of Health Care Workers database.